{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:50:00Z","timestamp":1782190200781,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bioenerg Biomembr"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10863-026-10088-z","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T07:23:54Z","timestamp":1774337034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epigenetic activation of PDLIM7 via H3K27 acetylation mitigates neuroinflammation and neurodegeneration in parkinson\u2019s disease models"],"prefix":"10.1007","volume":"58","author":[{"given":"Xinru","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengwei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"10088_CR1","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.4049\/jimmunol.1502643","volume":"196","author":"PR Bally, Alexander","year":"2016","unstructured":"Bally, Alexander PR, James W, Austin, Jeremy MB (2016) Genetic and epigenetic regulation of PD-1 expression. J Immunol 196:2431\u20132437","journal-title":"J Immunol"},{"key":"10088_CR2","unstructured":"Bloem BR, Okun MS, Klein C (2021) Lancet, vol 397. \u2018Parkinson\u2019s disease\u2019, pp 2284\u20132303"},{"key":"10088_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1177\/0963689717723636","volume":"27","author":"Y-H Chang","year":"2018","unstructured":"Chang Y-H, Wu K-C, Harn H-J, Lin S-Z, Dah-Ching D (2018) Exosomes and stem cells in degenerative disease diagnosis and therapy. Cell Transplant 27:349\u2013363","journal-title":"Cell Transplant"},{"key":"10088_CR4","doi-asserted-by":"publisher","first-page":"17027","DOI":"10.3390\/ijms242317027","volume":"24","author":"C-J Choong","year":"2023","unstructured":"Choong C-J, and Hideki Mochizuki (2023) Involvement of mitochondria in parkinson\u2019s disease. Int J Mol Sci 24:17027","journal-title":"Int J Mol Sci"},{"key":"10088_CR5","doi-asserted-by":"crossref","unstructured":"Da\u015bko M, de Pascual-Teresa B, Ort\u00edn I and A. Ramos (2022) \u2018HDAC Inhibitors: Innovative Strategies for Their Design and Applications\u2019. Molecules, 27","DOI":"10.3390\/molecules27030715"},{"key":"10088_CR27","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1042\/bj20021321","volume":"370","author":"AJM de Ruijter","year":"2003","unstructured":"de Ruijter AJM, Albert H, van Huib GENNIP N, Caron Stephan Kemp, and Andr\u00e9 BP van KUILENBURG (2003) \u2018Histone deacetylases (HDACs): characterization of the classical HDAC family\u2019. Biochem J 370:737\u2013749","journal-title":"Biochem J"},{"key":"10088_CR6","doi-asserted-by":"publisher","first-page":"26346","DOI":"10.1038\/s41598-024-76058-w","volume":"14","author":"R Duan","year":"2024","unstructured":"Duan R, Shi L, Deng Y, Wu J, Wang S, Peng Q, Li Z, Xu Z, Wang F, Xue X, Gao Q (2024) AVE0991 ameliorates dopaminergic neuronal damage in parkinson\u2019s disease through HOTAIRM1\/miR-223-3p\/\u03b1-synuclein axis. Sci Rep 14:26346","journal-title":"Sci Rep"},{"key":"10088_CR7","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/cdd.2009.216","volume":"17","author":"P Gaub","year":"2010","unstructured":"Gaub P, Tedeschi A, Puttagunta R, Nguyen T, Schmandke A, Di Giovanni S (2010) HDAC Inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP\/p300 and P\/CAF-dependent p53 acetylation. Cell Death Differ 17:1392\u20131408","journal-title":"Cell Death Differ"},{"key":"10088_CR8","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.tiv.2019.06.019","volume":"60","author":"PA Gonz\u00e1lez","year":"2019","unstructured":"Gonz\u00e1lez PA, Iglesias, Melisa A, Conde Ver\u00f3nica, Gonz\u00e1lez-Pardo RM, Uranga, Gabriela AS (2019) In vitro 6-hydroxydopamine-induced neurotoxicity: new insights on NF\u03baB modulation. Toxicol in Vitro 60:400\u2013411","journal-title":"Toxicol in Vitro"},{"key":"10088_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41419-023-05647-w","volume":"14","author":"L Guan","year":"2023","unstructured":"Guan L, Hao Q, Shi F, Gao B, Wang M, Zhou X, Han T, Wenjie Ren (2023) Regulation of the tumor immune microenvironment by cancer-derived circular RNAs. Cell Death Dis 14:132","journal-title":"Cell Death Dis"},{"key":"10088_CR10","doi-asserted-by":"publisher","first-page":"919343","DOI":"10.3389\/fnagi.2022.919343","volume":"14","author":"M Guo","year":"2022","unstructured":"Guo M, Ji X, Liu J (2022) Hypoxia and alpha-Synuclein: inextricable link underlying the pathologic progression of parkinson\u2019s disease. Front Aging Neurosci 14:919343","journal-title":"Front Aging Neurosci"},{"key":"10088_CR11","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1021\/acschemneuro.1c00215","volume":"12","author":"I Hlushchuk","year":"2021","unstructured":"Hlushchuk I, Ruskoaho H, Domanskyi A, Airavaara M, Mika JV (2021) Domain-independent Inhibition of CBP\/p300 attenuates \u03b1-synuclein aggregation. ACS Chem Neurosci 12:2273\u20132279","journal-title":"ACS Chem Neurosci"},{"key":"10088_CR13","doi-asserted-by":"publisher","first-page":"e138088","DOI":"10.1172\/jci.insight.138088","volume":"6","author":"M Huang","year":"2021","unstructured":"Huang M, Lou D, Charli A, Kong D, Jin H, Zenitsky G, Anantharam V, Kanthasamy A, Wang Z, Anumantha GK (2021) Mitochondrial dysfunction\u2013induced H3K27 hyperacetylation perturbs enhancers in parkinson\u2019s disease. JCI Insight 6:e138088","journal-title":"JCI Insight"},{"key":"10088_CR12","doi-asserted-by":"publisher","first-page":"1052925","DOI":"10.3389\/fimmu.2023.1052925","volume":"14","author":"M Huang","year":"2023","unstructured":"Huang M, Malovic E, Ealy A, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG (2023) Microglial immune regulation by epigenetic reprogramming through histone H3K27 acetylation in neuroinflammation. Front Immunol 14:1052925","journal-title":"Front Immunol"},{"key":"10088_CR14","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.3389\/fimmu.2020.01559","volume":"11","author":"A Jodo","year":"2020","unstructured":"Jodo A, Shibazaki A, Onuma A, Kaisho T, Tanaka T (2020) PDLIM7 synergizes with PDLIM2 and p62\/Sqstm1 to inhibit inflammatory signaling by promoting degradation of the p65 subunit of NF-\u03baB. Front Immunol 11:1559","journal-title":"Front Immunol"},{"key":"10088_CR15","doi-asserted-by":"publisher","first-page":"6168","DOI":"10.3390\/ijms25116168","volume":"25","author":"A Klokkaris","year":"2024","unstructured":"Klokkaris A, Migdalska-Richards A (2024) An overview of epigenetic changes in the parkinson\u2019s disease brain. Int J Mol Sci 25:6168","journal-title":"Int J Mol Sci"},{"key":"10088_CR16","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00401-016-1590-9","volume":"132","author":"C Labb\u00e9","year":"2016","unstructured":"Labb\u00e9 C, Lorenzo-Betancor O, Owen AR (2016) Epigenetic regulation in parkinson\u2019s disease. Acta Neuropathol 132:515\u2013530","journal-title":"Acta Neuropathol"},{"key":"10088_CR17","unstructured":"Lampugnani M, Grazia L, Bravi, and Elisabetta Dejana (2015). \u2018The role of microvascular endothelial WNT signaling the formation of the blood brain barrier\u2019, SpringerPlus, 4: L47"},{"key":"10088_CR18","first-page":"58","volume":"9","author":"Landgrave-G\u00f3mez","year":"2015","unstructured":"Landgrave-G\u00f3mez, Jorge Octavio Mercado-G\u00f3mez, and Rosalinda Guevara-Guzm\u00e1n (2015) \u2018Epigenetic mechanisms in neurological and neurodegenerative diseases\u2019. Front Cell Neurosci 9:58","journal-title":"Front Cell Neurosci"},{"key":"10088_CR19","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/mds.27360","volume":"33","author":"AE Lang","year":"2018","unstructured":"Lang AE, Alberto JE (2018) Disease modification in parkinson\u2019s disease: current approaches, challenges, and future considerations. Mov Disord 33:660\u2013677","journal-title":"Mov Disord"},{"key":"10088_CR20","unstructured":"Lesage S, Trinh J (2023) \u2018Special Issue Parkinson\u2019s Disease: Genetics and Pathogenesis\u2019, Genes (Basel), 14"},{"key":"10088_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40035-019-0162-z","volume":"8","author":"G Li","year":"2019","unstructured":"Li G, Ma J, Cui S, He Y, Xiao Q, Liu J, Chen S (2019) Parkinson\u2019s disease in china: a forty-year growing track of bedside work. Transl Neurodegener 8:22","journal-title":"Transl Neurodegener"},{"key":"10088_CR22","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.3390\/ijms26104929","volume":"26","author":"DB Olawade","year":"2025","unstructured":"Olawade DB, Intishar Rashad E, Egbon J, Teke SV, Ovsepian, Stergios Boussios (2025) Reversing epigenetic dysregulation in neurodegenerative diseases: mechanistic and therapeutic considerations. Int J Mol Sci 26:4929","journal-title":"Int J Mol Sci"},{"key":"10088_CR23","unstructured":"Pajares M, Rojo AI (2020) Gina Manda, Lisardo Bosc\u00e1, and Antonio Cuadrado. \u2018Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications\u2019, Cells, 9:1687"},{"key":"10088_CR24","doi-asserted-by":"publisher","first-page":"4956","DOI":"10.3390\/ijms22094956","volume":"22","author":"M Rasheed","year":"2021","unstructured":"Rasheed M, Liang J, Wang C, Deng Y, Chen Z (2021) Epigenetic regulation of neuroinflammation in parkinson\u2019s disease. Int J Mol Sci 22:4956","journal-title":"Int J Mol Sci"},{"key":"10088_CR25","doi-asserted-by":"publisher","first-page":"14171","DOI":"10.1021\/acs.jmedchem.5c01677","volume":"68","author":"A Raucci","year":"2025","unstructured":"Raucci A, Zwergel C, Valente S, Mai A (2025) Advancements in Hydrazide-Based HDAC inhibitors: A review of recent developments and therapeutic potential. J Med Chem 68:14171\u201314194","journal-title":"J Med Chem"},{"key":"10088_CR26","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1080\/17501911.2024.2419357","volume":"16","author":"C Rosete","year":"2024","unstructured":"Rosete C, Annie Vogel C (2024) The two faces of HDAC3: neuroinflammation in disease and neuroprotection in recovery. Epigenomics 16:1373\u20131388","journal-title":"Epigenomics"},{"key":"10088_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2217\/epi-2023-0416","volume":"16","author":"B S\u0142owikowski","year":"2024","unstructured":"S\u0142owikowski B, Owecki W, Jeske JMicha\u0142, Jezierski Micha\u0142, Dragu\u0142a Ulyana Goutor, Pawe\u0142 P Jagodzi\u0144ski, Wojciech Kozubski, Jolanta Dorszewska (2024) \u2018Epigenetics and the neurodegenerative process\u2019. Epigenomics 16:473\u2013491","journal-title":"Epigenomics"},{"key":"10088_CR29","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3390\/brainsci13010150","volume":"13","author":"A Surguchov","year":"2023","unstructured":"Surguchov A (2023) \u03b1-Synuclein and mechanisms of epigenetic regulation. Brain Sci 13:150","journal-title":"Brain Sci"},{"key":"10088_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of parkinson\u2019s disease. Lancet Neurol 20:385\u2013397","journal-title":"Lancet Neurol"},{"key":"10088_CR31","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ydbio.2013.11.005","volume":"385","author":"D Tsui","year":"2014","unstructured":"Tsui D, Voronova A, Gallagher D, Kaplan DR, Miller FD, Wang J (2014) CBP regulates the differentiation of interneurons from ventral forebrain neural precursors during murine development. Dev Biol 385:230\u2013241","journal-title":"Dev Biol"},{"key":"10088_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.tins.2024.01.002","volume":"47","author":"J Wang","year":"2024","unstructured":"Wang J, Dai L, Chen S, Zhang Z, Fang X, Zhang Z (2024) Protein-protein interactions regulating \u03b1-synuclein pathology. Trends Neurosci 47:209\u2013226","journal-title":"Trends Neurosci"},{"key":"10088_CR33","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1089\/thy.2023.0497","volume":"34","author":"F Yang","year":"2024","unstructured":"Yang F, Yang M, Liu Y, Zhou C, Chen Y, Wu J, Zhang X, Shengjun Xiao (2024) PDLIM7 promotes tumor metastasis in papillary thyroid carcinoma via stabilizing focal adhesion kinase protein. Thyroid 34:598\u2013610","journal-title":"Thyroid"},{"key":"10088_CR34","doi-asserted-by":"publisher","first-page":"13042","DOI":"10.3390\/ijms252313042","volume":"25","author":"M Zhou","year":"2024","unstructured":"Zhou M, Xu K, Ge J, Luo X, Wu M, Wang N, and Jianfeng Zeng (2024) Targeting ferroptosis in parkinson\u2019s disease: mechanisms and emerging therapeutic strategies. Int J Mol Sci 25:13042","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Bioenergetics and Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-026-10088-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10863-026-10088-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-026-10088-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:30:04Z","timestamp":1782189004000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10863-026-10088-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10088"],"URL":"https:\/\/doi.org\/10.1007\/s10863-026-10088-z","relation":{},"ISSN":["0145-479X","1573-6881"],"issn-type":[{"value":"0145-479X","type":"print"},{"value":"1573-6881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Joint Ethics Committee of the Ministry of Health, China (Approval No. HUZ2025-NEURO-PD-037) and followed ARRIVE and Declaration of Helsinki guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"NA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}